NCT02626364 2020-07-20
Study of Crenolanib in Recurrent/Refractory Glioblastoma With PDGFRA Gene Amplification
Arog Pharmaceuticals, Inc.
Phase 2 Completed
Clinical Trials
3 trialsNCT01229644 2018-07-05
Study of Crenolanib, a Selective and Potent Inhibitor of PDGFR, for the Treatment of Adult Gliomas
Arog Pharmaceuticals, Inc.
Phase 2 Terminated
NCT01393912 2017-04-26
PDGFR Inhibitor Crenolanib in Children/Young Adults With Diffuse Intrinsic Pontine Glioma or Recurrent High-Grade Glioma
St. Jude Children's Research Hospital
Phase 1 Completed